101 results
Page 5 of 6
10-K
EX-4.3
b924o91nlat
16 Feb 21
Annual report
4:11pm
10-K
n8he gv6csdfls0jq
16 Feb 21
Annual report
4:11pm
8-K
EX-99.1
dhq44
16 Feb 21
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update
4:05pm
8-K
ar8v96ap zd
7 Dec 20
Regulation FD Disclosure
6:06am
8-K
EX-99.1
vcj 33am9zl6h
26 Oct 20
Nurix Therapeutics Announces Appointment of Robert Tjian as Chairman of Scientific Advisory Board and His Resignation from the Board of Directors
4:05pm
8-K
EX-99.1
nhfzguxrvw0 hrgwu70
14 Oct 20
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update
4:05pm
10-Q
2oxjt0ozkd75i6
14 Oct 20
Quarterly report
4:02pm
10-Q
EX-3.2
64lipzr
14 Oct 20
Quarterly report
4:02pm
8-K
EX-99.1
9lhz24c27mjy2
14 Oct 20
Regulation FD Disclosure
2:01pm
424B4
4l7kvxwq
24 Jul 20
Prospectus supplement with pricing info
4:06pm
S-1/A
qoqxpp12q9 xn
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
EX-1.1
0hqabl hyunzcci2mm7
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
EX-3.4
j3ak wblir6kc8
20 Jul 20
IPO registration (amended)
6:32am
S-1
EX-10.10
tlboczfr kc548g4v6ep
2 Jul 20
IPO registration
4:04pm
S-1
EX-10.9
yl7yoi 3z09
2 Jul 20
IPO registration
4:04pm
S-1
0w69dulw0 kv3
2 Jul 20
IPO registration
4:04pm
DRS/A
7u5pu8 gr0irlvy09mm9
10 Jun 20
Draft registration statement (amended)
12:00am
DRS
yodh570 sg6
5 May 20
Draft registration statement
12:00am
DRS
EX-10.9
dkg9sqp7nngkf7
5 May 20
Draft registration statement
12:00am